Blueprint Medicines shares owned by Carillon Tower Advisers
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Carillon Tower Advisers
from 13F filings
Historical chart of Carillon Tower Advisers investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Carillon Tower Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Carillon Tower Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2020-12-31 | $37M | 330k | 112.15 |
| 2020-09-30 | $23M | 365k | 62.58 |
| 2020-06-30 | $32M | 407k | 78.00 |
| 2020-03-31 | $23M | 407k | 57.09 |
| 2019-12-31 | $45M | 566k | 80.11 |
| 2019-09-30 | $42M | 566k | 73.47 |
| 2019-06-30 | $53M | 566k | 94.33 |
| 2019-03-31 | $45M | 566k | 80.05 |
| 2018-12-31 | $31M | 566k | 53.91 |
| 2018-09-30 | $44M | 566k | 78.06 |